Induction of in vitro nuclear apoptosis activity coincides with the production of 50 kDa cytosolic protein

Cell Death and Differentiation

Volumn 4, Issue 7, 1997, Pages 617-622

  Naito, Mikihiko ^a   Shiina, Kayo ^a   Mashima, Tetsuo ^a   Nagashima, Kimie ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Cell free apoptosis; Cytosol; Monoclonal antibody; U937

Indexed keywords

EID: 0344993409     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400287     Document Type: Article

References (43)

1. An B and Dou QP (1996) Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res. 56: 438-442
2. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
3. Chen Z, Naito M, Mashima T and Tsuruo T (1996) Activation of actin-cleavable ICE family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res. 56: 5224-5229
4. Cohen JJ, Duke RC, Fadok VA and Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10: 267-293
5. Collins MK and Lopez Rivas A (1993) The control of apoptosis in mammalian cells. Trends Biochem. Sci. 18: 307-309
6. Duvall E and Wyllie AH (1986) Death and the cell. Immunol. Today 7: 115-119
7. Earnshaw WC (1995) Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7: 337-343
8. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R and Kufe D (1995) Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J. 14: 6148-6156
9. Enari M, Talanian RV, Wong WW and Nagata S (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723-726
10. Fisher DE (1994) Apoptosis in cancertherapy: crossing the threshold. Cell 78: 539-542
11. Fujita N, Kataoka S, Naito M, Heike Y, Boku N, Nakajima M and Tsuruo T (1993) Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules. Cancer Res. 53: 5022-5027
12. Gu Y, Sarnecki C, Aldape RA, Livingston DJ and Su MS (1995) Cleavage of poly(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2. J. Biol. Chem. 270: 18715-18718
13. Han Z, Malik N, Carter T, Reeves WH, Wyche JH and Hendrickson EA (1996) DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease. J. Biol. Chem. 271: 25035-25040
14. Kataoka S, Naito M, Fujita N, Ishii S, Ishii H, Yamori T, Nakajima M and Tsuruo T (1993) Control of apoptosis and growth of malignant T lymphoma cells by lymph node stromal cells. Exp. Cell Res. 207: 271-276
15. Kataoka S, Naito M, Tomida A and Tsuruo T (1994) Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells. Exp. Cell Res. 215: 199-205
16. Kaufmann SH (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49: 5870-5878
17. Kroemer G, Petit P, Zamzami N, Vayssiere JL and Mignotte B (1995) The biochemistry of programmed cell death. FASEB J. 9: 1277-1287
18. Kumar S (1995) ICE-like proteases in apoptosis. Trends Biochem. Sci. 20: 198-202
19. Lazebnik YA, Cole S, Cooke CA, Nelson WG and Earnshaw WC (1993) Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 123: 7-22
20. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH and Earnshaw WC (1995) Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA 92: 9042-9046
21. Leist M, Gantner F, Jilg S and Wendel A. (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154: 1307-1316
22. Liu X, Kim CN, Yang J, Jemmerson R and Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157
23. Martin SJ, Newmeyer DD, Mathias S, Farschon DM, Wang HG, Reed JC, Kolesnick RN and Green DR (1995) Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J. 14: 5191-5200
24. Mashima T, Naito M, Fujita N, Noguchi K and Tsuruo T (1995a) Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun. 217: 1185-1192
25. Mashima T, Naito M, Kataoka S, Kawai H and Tsuruo T (1995b) Aspartate-based inhibitor of interteukin-1β-converting enzyme prevent antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. Biophys. Res. Commun. 209: 907-915
26. Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW and Tsuruo T (1997) Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14: 1007-1012
27. Naito M, Nagashima K, Mashima T and Tsuruo T (1997) Phosphatidylserine externalization is a downstream event of interleukin-1b-converting enzyme family protease activation during apoptosis. Blood 89: 2060-2066
28. Newmeyer DD, Farschon DM and Reed JC (1994) Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79: 353-364
29. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43
30. Noguchi K, Naito M, Kugou H, Oshimura M, Mashima T, Fujita N, Yonehara S and Tsuruo T (1996) Chromosome 22 complements apoptosis in Fas- and TNF-resistant mutant UK110 cells. Oncogene 13: 39-46
31. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S and Hanada M (1996) BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60: 23-32
32. Schlegel J, Peters I and Orrenius S (1995) Isolation and partial characterization of a protease involved in Fas-induced apoptosis. FEBS Lett. 364: 139-142
33. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H and Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374: 811-813
34. Steller H (1995) Mechanism and genes of cellular suicide. Science 267: 1445-1449
35. Sucin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geusken M and Kroemer G (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184: 1331-1341
36. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
37. Tewari M, Beidler DR and Dixit VM (1995a) CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270: 18738-18741
38. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen Gs and Dixit VM (1995b) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809
39. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462
40. Vaux DL (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90: 786-789
41. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291
42. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M and Guido K (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183: 1533-1544
43. Zha H, Aime-Sempe C, Sato T and Reed JC (1996) Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271: 7440-7444